Martin Pruschy

5.5k total citations
108 papers, 4.3k citations indexed

About

Martin Pruschy is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Martin Pruschy has authored 108 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Molecular Biology, 43 papers in Oncology and 32 papers in Cancer Research. Recurrent topics in Martin Pruschy's work include Cancer, Hypoxia, and Metabolism (25 papers), Radiation Therapy and Dosimetry (14 papers) and Cancer Treatment and Pharmacology (13 papers). Martin Pruschy is often cited by papers focused on Cancer, Hypoxia, and Metabolism (25 papers), Radiation Therapy and Dosimetry (14 papers) and Cancer Treatment and Pharmacology (13 papers). Martin Pruschy collaborates with scholars based in Switzerland, United States and Germany. Martin Pruschy's co-authors include Stephan Bodis, Oliver Riesterer, Van Vuong, Barry M. Gumbiner, William M. Brieher, Alpha S. Yap, Sónia Rocha, Alexander Knuth, Anurag Gupta and Irma Telarović and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and The Journal of Cell Biology.

In The Last Decade

Martin Pruschy

105 papers receiving 4.2k citations

Peers

Countries citing papers authored by Martin Pruschy

Since Specialization

Citations

This map shows the geographic impact of Martin Pruschy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Pruschy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Pruschy more than expected).

Fields of papers citing papers by Martin Pruschy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Pruschy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Pruschy. The network helps show where Martin Pruschy may publish in the future.

Co-authorship network of co-authors of Martin Pruschy

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Pruschy. A scholar is included among the top collaborators of Martin Pruschy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Pruschy. Martin Pruschy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Live-cell imaging and analysis of 3D spheroids in hypoxia- and radiotherapy-related research 2025 ·Clinical and Translational Radiation Oncology ·(unknown), (unknown), (unknown), Martin Pruschy	0
2	Catalytically Active Ti‐Based Nanomaterials for Hydroxyl Radical Mediated Clinical X‐Ray Enhancement 2024 ·Advanced Science ·Lukas R. H. Gerken, (unknown), (unknown), Vera M. Kissling, Alexander Gogos, (unknown), Maria R. Lukatskaya, (unknown), Ludwig Plaßwilm, Martin Pruschy, Inge K. Herrmann	5
3	Delayed tumor-draining lymph node irradiation preserves the efficacy of combined radiotherapy and immune checkpoint blockade in models of metastatic disease 2024 ·Nature Communications ·Irma Telarović, Carmen S. Yong, (unknown), (unknown), (unknown), (unknown), Hung‐Wei Cheng, (unknown), Matthias Gückenberger, Anja Kipar, Burkhard Ludewig, Martin Pruschy	24
4	Mitochondria-targeted antioxidant MitoQ radiosensitizes tumors by decreasing mitochondrial oxygen consumption 2024 ·Cell Death Discovery ·(unknown), (unknown), (unknown), (unknown), (unknown), Lionel Mignion, Maurício Morais, (unknown), (unknown), Tânia Capelôa, Martin Pruschy, Bernard Gallez, Pierre Sonveaux	6
5	The role of EphA2 in ADAM17- and ionizing radiation-enhanced lung cancer cell migration 2023 ·Frontiers in Oncology ·Verena Waller, (unknown), (unknown), Martin Pruschy	5
6	Immunological and tumor-intrinsic mechanisms mediate the synergistic growth suppression of experimental glioblastoma by radiotherapy and MET inhibition 2023 ·Acta Neuropathologica Communications ·Manuela Silginer, Eleanna Papa, Emese Szabó, Flavio Vasella, Martin Pruschy, Christopher Stroh, Patrick Roth, Tobias Weiß, Michael Weller	3
7	Paracrine Placental Growth Factor Signaling in Response to Ionizing Radiation Is p53-Dependent and Contributes to Radioresistance 2021 ·Molecular Cancer Research ·(unknown), (unknown), Ashish Sharma, Irma Telarović, Marco Wachtel, (unknown), Beat W. Schäfer, Martin Pruschy	4
8	Systematic Review on the Association of Radiomics with Tumor Biological Endpoints 2021 ·Cancers ·(unknown), Diem Vuong, (unknown), Janita E. van Timmeren, (unknown), Verena Waller, Martin Pruschy, Matthias Gückenberger, Stephanie Tanadini‐Lang	18
9	NKG2D-Dependent Antitumor Effects of Chemotherapy and Radiotherapy against Glioblastoma 2017 ·Clinical Cancer Research ·Tobias Weiß, Hannah Schneider, Manuela Silginer, Alexander Steinle, Martin Pruschy, Bojan Polić, Michael Weller, Patrick Roth	90
10	Post-radiochemotherapy PET radiomics in head and neck cancer – The influence of radiomics implementation on the reproducibility of local control tumor models 2017 ·Radiotherapy and Oncology ·Marta Bogowicz, Ralph T. H. Leijenaar, Stephanie Tanadini‐Lang, Oliver Riesterer, Martin Pruschy, Gabriela Studer, Jan Unkelbach, Matthias Gückenberger, Ender Konukoğlu, Philippe Lambin	77
11	The novel microtubule targeting agent BAL101553 in combination with radiotherapy in treatment-refractory tumor models 2017 ·Radiotherapy and Oncology ·Ashish Sharma, Angela Broggini‐Tenzer, Van Vuong, (unknown), Katarzyna J. Nytko, Matthias Gückenberger, Felix Bachmann, Heidi A. Lane, Martin Pruschy	7
12	Tropomyosin receptor kinase C (TrkC) expression in medulloblastoma: relation to the molecular subgroups and impact on treatment response 2017 ·Child s Nervous System ·Carsten Friedrich, Tarek Shalaby, Christoph Oehler, Martin Pruschy, Burkhardt Seifert, Daniel Picard, Marc Remke, Monika Warmuth‐Metz, Rolf‐Dieter Kortmann, Stefan Rutkowski, Michael A. Grotzer, André O. von Bueren	4
13	Secretome Signature Identifies ADAM17 as Novel Target for Radiosensitization of Non–Small Cell Lung Cancer 2016 ·Clinical Cancer Research ·Ashish Sharma, Sabine Bender, Martina Zimmermann, Oliver Riesterer, Angela Broggini‐Tenzer, Martin Pruschy	35
14	Complement Is a Central Mediator of Radiotherapy-Induced Tumor-Specific Immunity and Clinical Response 2015 ·Immunity ·Laura Surace, Veronika Lysenko, A. Fontana, Virginia Cecconi, Hans Janßen, (unknown), Michał Okoniewski, Martin Pruschy, Reinhard Dummer, Jacques Neefjes, Alexander Knuth, Anurag Gupta, Maries van den Broek	138
15	Ionizing radiation and inhibition of angiogenesis in a spontaneous mammary carcinoma and in a syngenic heterotopic allograft tumor model: a comparative study 2011 ·Radiation Oncology ·Oliver Riesterer, Christoph Oehler‐Jänne, Wolfram Jochum, Angela Broggini‐Tenzer, Van Vuong, Martin Pruschy	6
16	Bone morphogenetic protein-7 is a MYC target with prosurvival functions in childhood medulloblastoma 2011 ·Oncogene ·Giulio Fiaschetti, Deborah Castelletti, Stefan Zoller, Alexander Schramm, Christina I. Schroeder, Masaya Nagaishi, Duncan Stearns, Michel Mittelbronn, Angelika Eggert, Frank Westermann, Hideaki Ohgaki, (unknown), Martin Pruschy, Alexandre Arcaro, Michael A. Grotzer	21
17	Impact of Genomic Methylation on Radiation Sensitivity of Colorectal Carcinoma 2010 ·International Journal of Radiation OncologyBiologyPhysics ·Barbara Hofstetter, Andrzej Niemierko, (unknown), Jean Benhattar, Veronica Albertini, Martin Pruschy, Fred T. Bosman, Carlo V. Catapano, I. Frank Ciernik	42
18	RNA interference-mediated c-MYC inhibition prevents cell growth and decreases sensitivity to radio- and chemotherapy in childhood medulloblastoma cells 2009 ·BMC Cancer ·André O. von Bueren, Tarek Shalaby, Christoph Oehler‐Jänne, (unknown), Duncan Stearns, Charles G. Eberhart, Alexandre Arcaro, Martin Pruschy, Michael A. Grotzer	40
19	Ceramide Induces Cytochrome c Release from Isolated Mitochondria 1999 ·Journal of Biological Chemistry ·Pedram Ghafourifar, Sabine D. Klein, (unknown), Ursula Schenk, Martin Pruschy, Sónia Rocha, Christoph Richter	232
20	The Proto-oncogene c-fos Mediates Apoptosis in Murine T-Lymphocytes Induced by Ionizing Radiation and Dexamethasone 1997 ·Biochemical and Biophysical Research Communications ·Martin Pruschy, Yuquan Shi, N. E. A. Crompton, Jörg Steinbach, Adriano Aguzzi, Christoph Glanzmann, Stephan Bodis	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact